CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Shenzhen YHLO Biotech Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Shenzhen YHLO Biotech Co Ltd
No. 65, Baolong 2nd Road
Baolong Neighbourhood, Longgang District
Phone: +86 75526473359p:+86 75526473359 SHENZHEN, GNG  518116  China Ticker: 688575688575
Business Summary
Shenzhen YHLO Biotech Co Ltd is a China-based company principally engaged in the research and development, manufacture and sales of in-vitro diagnostic equipment and supporting reagents, as well as the agency sales of some non-self-produced medical device products. The Company's products are applied in autoimmunity, reproductive health, diabetes and infectious disease fields. The Company's main products include in-vitro diagnostic instruments and supporting reagents based on chemiluminescence, immunoblotting, enzyme-linked immunoassay, immunofluorescence chromatography and other methodologies. The Company distributes its products in domestic market and to overseas markets.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
3/31/202412/31/2023Yes----

Industries
SIC Code Description
3841 Surgical and medical instruments and apparatus
2835 In vitro and in vivo diagnostic substances
3842 Orthopedic, prosthetic, and surgical appliances and supplies
5122 Drugs, drug proprietaries, and druggists' sundries
5047 Medical, dental, and hospital equipment and supplies

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board KunhuiHu 32 10/27/2023 11/5/2021
Vice Chairman of the Board, General Manager YongboSong 37 11/5/2021 11/5/2021
Chief Financial Officer, Director LishengLiao 44 12/30/2022 12/30/2022
6 additional Officers and Directors records available in full report.

General Information
Number of Employees: 1,759 (As of 12/31/2023)
Outstanding Shares: 568,308,500 (As of 3/31/2024)
Shareholders: 8,357
Stock Exchange: SHA
Fax Number: +86 75526473319


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, April 24, 2024